MedPath

The safety and efficacy of Yu-Qi-Dai (Yu-Qi Tai-Du-Qing) for the prevention of neonatal jaundice

Not Applicable
Conditions
neonatal jaundice
Registration Number
ITMCTR1900002820
Lead Sponsor
Jiangxi TongTianLe Technology Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Neonates born within 0 to 1 day;
(2) Birth weight: 2500 to 4000g;
(3) Apgar score: 7 to 10 points;
(4) By vaginal delivery or caesarean delivery, gestational age: 37 to 42 weeks;
(5) The age of the mother is 23 to 35 years old;
(6) The mother has no pregnancy, childbirth complications and complications.

Exclusion Criteria

(1) Newborns with birth injury;
(2) Newborns with malformation or other disease;
(3) Severe neonatal hemolytic;
(4) Either of the parents has a history of allergies.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effective rate;
Secondary Outcome Measures
NameTimeMethod
Transcutaneous bilirubin;Timing of passage of first meconium;Timing of meconium turned yellow;Timing of onset of jaundice ;Status of falling-off of umbilical cord;Timing of jaundice subsided;
© Copyright 2025. All Rights Reserved by MedPath